Home

Ponoi II Management, LLC

CIK 1746488 · last filed 2024-04-08

Ponoi II Management, LLC is a corporate insider who has filed 15 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for NGM, was dated Apr 8, 2024. Across all open-market trades the lifetime net is −$699.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $519.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$519.08M

Companies

3

Total Filings

15

Lifetime Open-Market Net

-$699.31M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NGM BIOPHARMACEUTICALS INC (NGM) Delisted 10%+ Owner 0 $1.54 $0 $78.26M 11 2024-04-08
RAPT Therapeutics, Inc. (RAPT) Delisted 10%+ Owner 375,178 $58.01 $21.76M -$113.48M 2 2021-09-29
RVMD 10%+ Owner 2,836,037 $183.03 $519.08M -$664.10M 2 2020-11-18

Recent Filings

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-04-08 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Mixed −217,424,130 $0 EDGAR
2022-10-31 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +768,770 $3.74M EDGAR
2022-05-13 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +1,663,500 $19.02M EDGAR
2021-09-29 RAPT Therapeutics, Inc. (RAPT) Delisted Mixed — -$705.8K EDGAR
2020-11-18 RVMD Sell (S) −18,244,404 -$664.10M EDGAR
2020-08-19 RAPT Therapeutics, Inc. (RAPT) Delisted Sell (S) −4,847,886 -$110.29M EDGAR
2020-08-03 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +7,320 $131.7K EDGAR
2020-06-19 RVMD Other (J) +65,106 $0 EDGAR
2019-10-11 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +531,720 $5.55M EDGAR
2019-08-09 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Buy (P) +2,246,640 $31.45M EDGAR
Showing 1–10 of 15
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.